GLP-1s (full name: glucagon-like peptide-1 receptor agonists, or GLP-1 agonists) help the pancreas release insulin, reduce blood sugar, slow the rate of stomach emptying, and increase feelings of fullness, explains Gretchen Zimmermann, RD, a registered dietitian specializing in obesity and vice president of clinical strategy at Vida Health
Our team offers advanced peptide therapies, including BPC-157 injections, in a welcoming and patient-focused environment designed around your needs and goals
Our most comprehensive program for optimal results
All of this makes it difficult to rigorously compare data from multiple studies
Book a visit and we will confirm your tier, gather the documentation, and submit your prior authorization